Frontiers in Laboratory Medicine最新文献

筛选
英文 中文
Small cell carcinoma of the endometrium: A case report with circulating tumor cell clusters 子宫内膜小细胞癌伴循环肿瘤细胞团1例报告
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/J.FLM.2017.11.004
Yongpeng He, Hai-jian Huang, Haixiang Wang, Lin Yi, Yichao Chen, Haiwei Zhang, Jing Ran, Hesong Shen, Qingming Jiang, Weiqi Nian
{"title":"Small cell carcinoma of the endometrium: A case report with circulating tumor cell clusters","authors":"Yongpeng He, Hai-jian Huang, Haixiang Wang, Lin Yi, Yichao Chen, Haiwei Zhang, Jing Ran, Hesong Shen, Qingming Jiang, Weiqi Nian","doi":"10.1016/J.FLM.2017.11.004","DOIUrl":"https://doi.org/10.1016/J.FLM.2017.11.004","url":null,"abstract":"","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"37 1","pages":"179-181"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83373720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A simple assay for direct colorimetric detection of prostatic acid phosphatase (PAP) at fg levels using biphosphonated loaded PEGylated gold nanoparticles 一种使用双磷酸负载聚乙二醇化金纳米颗粒直接比色法检测前列腺酸性磷酸酶(PAP)在fg水平的简单方法
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/J.FLM.2017.11.005
M. B. Haddada, Fatima Aouidat, M. Monteil, M. Lecouvey, M. L. Chapelle, J. Spadavecchia
{"title":"A simple assay for direct colorimetric detection of prostatic acid phosphatase (PAP) at fg levels using biphosphonated loaded PEGylated gold nanoparticles","authors":"M. B. Haddada, Fatima Aouidat, M. Monteil, M. Lecouvey, M. L. Chapelle, J. Spadavecchia","doi":"10.1016/J.FLM.2017.11.005","DOIUrl":"https://doi.org/10.1016/J.FLM.2017.11.005","url":null,"abstract":"","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"135 1","pages":"186-191"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86827636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Relationship between oxidative stress in patients with HBV-induced liver disease and HBV genotype/drug-resistant mutation HBV诱导肝病患者氧化应激与HBV基因型/耐药突变的关系
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/j.flm.2017.12.005
Jia-fu Feng , Yu-wei Yang , Dong Wang , Jie Tang , Gang Xie , Ling-ying Fan
{"title":"Relationship between oxidative stress in patients with HBV-induced liver disease and HBV genotype/drug-resistant mutation","authors":"Jia-fu Feng ,&nbsp;Yu-wei Yang ,&nbsp;Dong Wang ,&nbsp;Jie Tang ,&nbsp;Gang Xie ,&nbsp;Ling-ying Fan","doi":"10.1016/j.flm.2017.12.005","DOIUrl":"https://doi.org/10.1016/j.flm.2017.12.005","url":null,"abstract":"<div><h3>Objective</h3><p>To explore the correlation of oxidative stress in patients with chronic hepatitis B and degree of severity of the disease with HBV genotype and drug-resistant mutation.</p></div><div><h3>Methods</h3><p>A total of 296 patients with diagnosed chronic hepatitis B were selected from Febuary 2014 to April 2016 in Mianyang Central Hospital, including 145 cases of chronic hepatitis B (CHB), 101 cases of hepatitis B cirrhosis (HBC), and 50 cases of hepatocellular carcinoma (HCC). Three HBV genotypes (B, C and D) and eight drug-resistant mutation genes (rt180L, rt204M, rt207V, rt236N, rt250M, rt181A, rt184T and rt202S) were detected by PCR-reverse dot blot method. In addition, total oxidative stress (TOS), and total antioxidant status (TAS) were measured, on the basis of which oxidative stress index (OSI) was calculated. Furthermore, the differences of TOS, TAS and OSI levels were compared between different liver diseases, different genotypes or drug-resistant mutation, and also the correlations were analyzed between HBV genotype, drug-resistant mutation, patient’s oxidative stress status and disease severity.</p></div><div><h3>Results</h3><p>Serum TOS and OSI levels, HBV-B/C ratios and drug-resistant mutation rates increased gradually with the severity of liver disease (CHB &lt; HBC&lt;HCC, <em>P</em> &lt; 0.05). Serum TAS levels decreased with degree of severity of the disease, but there was no statistical difference between CHB group and HCC group. Except TAS levels in patients at PHC group, compared with patients without mutation in HBV, the patients with drug-resistant mutation had higher TOS and OSI levels, but lower serum TAS levels (<em>P</em> &lt; 0.05). Drug-resistant mutation rate was positively correlated with TOS (<em>r</em> = 0.476, <em>P</em> &lt; 0.001) and OSI (<em>r</em> = 0.441, <em>P</em> &lt; 0.001) levels, but negatively correlated with TAS level (<em>r</em> = −0.249, <em>P</em> &lt; 0.001), except TAS level in patients at PHC group. In addition, the number of mutation sites was positively correlated with disease severity (<em>γ</em> = 0.614, <em>P</em> &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>There are different degrees of oxidative damage in patients with HBV-induced liver disease, and the degree of the damage depends on HBV genotypes and drug-resistant mutations. Therefore, oxidative stress parameters might be useful indicators of progression of HBV-induced liver disease in patients.</p></div>","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"1 4","pages":"Pages 211-216"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.flm.2017.12.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91725526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The association between long noncoding RNA H19 and pathological features in cancers: A meta-analysis 长链非编码RNA H19与癌症病理特征之间的关系:一项荟萃分析
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/J.FLM.2017.12.002
Meng Cui, Qing Luo, Yi Zhang, Kai Zhang, Jinbo Liu
{"title":"The association between long noncoding RNA H19 and pathological features in cancers: A meta-analysis","authors":"Meng Cui, Qing Luo, Yi Zhang, Kai Zhang, Jinbo Liu","doi":"10.1016/J.FLM.2017.12.002","DOIUrl":"https://doi.org/10.1016/J.FLM.2017.12.002","url":null,"abstract":"","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"151 1","pages":"203-210"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77989917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The analysis of the detection performance of nucleic acid testing and ELISA for HIV, HBV and HCB 核酸检测与酶联免疫吸附法检测HIV、HBV、HCB的性能分析
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/J.FLM.2017.12.004
Wei Huang, Wei Wei, Xiao Shi, Tianlun Jiang
{"title":"The analysis of the detection performance of nucleic acid testing and ELISA for HIV, HBV and HCB","authors":"Wei Huang, Wei Wei, Xiao Shi, Tianlun Jiang","doi":"10.1016/J.FLM.2017.12.004","DOIUrl":"https://doi.org/10.1016/J.FLM.2017.12.004","url":null,"abstract":"","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"55 1","pages":"200-202"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73099944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Biological functions of miR-590 and its role in carcinogenesis miR-590的生物学功能及其在癌变中的作用
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/J.FLM.2017.11.002
Yang Dong, G. Qiu
{"title":"Biological functions of miR-590 and its role in carcinogenesis","authors":"Yang Dong, G. Qiu","doi":"10.1016/J.FLM.2017.11.002","DOIUrl":"https://doi.org/10.1016/J.FLM.2017.11.002","url":null,"abstract":"","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"54 1","pages":"173-176"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81056363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
The association between long noncoding RNA H19 and pathological features in cancers: A meta-analysis 长链非编码RNA H19与癌症病理特征之间的关系:一项荟萃分析
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/j.flm.2017.12.002
Meng Cui, Qing Luo, Yi Zhang, Kaijiong Zhang, Jinbo Liu
{"title":"The association between long noncoding RNA H19 and pathological features in cancers: A meta-analysis","authors":"Meng Cui,&nbsp;Qing Luo,&nbsp;Yi Zhang,&nbsp;Kaijiong Zhang,&nbsp;Jinbo Liu","doi":"10.1016/j.flm.2017.12.002","DOIUrl":"https://doi.org/10.1016/j.flm.2017.12.002","url":null,"abstract":"<div><h3>Purpose</h3><p>Long noncoding RNA (lncRNA) H19 has been reported to be up-regulated and down-regulated in numerous tumors, but the relevance of clinical pathological features is not established. So, meta-analysis was conducted to investigate the association between H19 expression and pathological features of cancers.</p></div><div><h3>Method</h3><p>The databases on PubMed, Web of Science, CNKI, and Wan Fang were searched for the related studies. 13 eligible studies were included with a total of 854 patients. Revman5.3 and Stata12.0 software were performed to analyze the data.</p></div><div><h3>Results</h3><p>The results suggested that the group of high H19 expression had a higher risk of poorly histological grade, clinical stage, deep tumor invasion (T2 stage or more), and was inclined to lymphatic metastasis, distant metastasis, and had a shorter survival time than the group of low H19 expression.</p></div><div><h3>Conclusion</h3><p>High expression of lncRNAH19 might act as a novel diagnostic biomarker and predict poor oncological outcomes of patients with cancers.</p></div>","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"1 4","pages":"Pages 203-210"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.flm.2017.12.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91725522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The analysis of the detection performance of nucleic acid testing and ELISA for HIV, HBV and HCB 核酸检测与酶联免疫吸附法检测HIV、HBV、HCB的性能分析
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/j.flm.2017.12.004
Wei Huang , Wei Wei , Xiao Tian Shi , Tianlun Jiang
{"title":"The analysis of the detection performance of nucleic acid testing and ELISA for HIV, HBV and HCB","authors":"Wei Huang ,&nbsp;Wei Wei ,&nbsp;Xiao Tian Shi ,&nbsp;Tianlun Jiang","doi":"10.1016/j.flm.2017.12.004","DOIUrl":"https://doi.org/10.1016/j.flm.2017.12.004","url":null,"abstract":"<div><h3>Objective</h3><p>To explore the clinical efficacy of Nucleic acid testing (NAT) in combination with Enzyme linked immunosorbent assay (ELISA).</p></div><div><h3>Methods</h3><p>Between January 2015 and December 2016, 106,488 specimens from hospitalized patients were detected for HIV, HBV, and HCV by using NAT plus ELISA to compare the positive and negative coincidence rate in the same patient.</p></div><div><h3>Results</h3><p>99.85% (106,324) HIV results, 94.80% (100,951) HBV results and 99.45% (105,902) HCV results were identical by both tests. The results, showing NAT<sup>+</sup>/ELISA<sup>−</sup>, for HIV, HBV, and HCV were 21, 316 and 0 respectively, and the results, showing NAT<sup>+</sup>/ELISA<sup>−</sup>, for HIV, HBV, and HCV were 143, 4958 and 586 respectively.</p></div><div><h3>Conclusions</h3><p>The combination of NAT and ELISA could effectively improve the detection accuracy and screening efficiency for HIV, HBV and HCV, decrease the rate of missed detection, and reduce the risk of iatrogenic infection.</p></div>","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"1 4","pages":"Pages 200-202"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.flm.2017.12.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91725523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Using the VAP lipid panel for the detection, evaluation, and treatment of patients “at risk” for CAD 使用VAP脂质面板检测、评估和治疗冠心病“危险”患者
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/j.flm.2017.11.001
Kenneth French , Yi Wang , Jianghua Jia , Yusheng Zhang
{"title":"Using the VAP lipid panel for the detection, evaluation, and treatment of patients “at risk” for CAD","authors":"Kenneth French ,&nbsp;Yi Wang ,&nbsp;Jianghua Jia ,&nbsp;Yusheng Zhang","doi":"10.1016/j.flm.2017.11.001","DOIUrl":"https://doi.org/10.1016/j.flm.2017.11.001","url":null,"abstract":"<div><p>In the past several decades, multiple clinical trials have demonstrated the effects of dyslipidemia beyond low density lipoprotein cholesterol (LDL-C) on predicting risk for atherosclerosis and cardiovascular disease. In recent years there has been a proliferation of lipoprotein markers that, when used with LDL-C, help healthcare providers assess risk of patients on the basis of the cardiovascular risk spectrum. In this review, we will discuss some of the important reasons why traditional lipoprotein testing has failed in high risk populations and how unique lipoprotein testing by the Vertical Auto Profile (VAP) Lipid panel is to provide significant clarity to a difficult disease for its management and treatment. We will also discuss some of the new trials that address newer markers of risk that have robust outcomes even after adjusting for traditional cardiovascular disease risk factors.</p></div>","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"1 4","pages":"Pages 182-185"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.flm.2017.11.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91725527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using the VAP lipid panel for the detection, evaluation, and treatment of patients “at risk” for CAD 使用VAP脂质面板检测、评估和治疗冠心病“危险”患者
Frontiers in Laboratory Medicine Pub Date : 2017-12-01 DOI: 10.1016/J.FLM.2017.11.001
K. French, Yi Wang, J. Jia, Yusheng Zhang
{"title":"Using the VAP lipid panel for the detection, evaluation, and treatment of patients “at risk” for CAD","authors":"K. French, Yi Wang, J. Jia, Yusheng Zhang","doi":"10.1016/J.FLM.2017.11.001","DOIUrl":"https://doi.org/10.1016/J.FLM.2017.11.001","url":null,"abstract":"","PeriodicalId":100555,"journal":{"name":"Frontiers in Laboratory Medicine","volume":"26 1","pages":"182-185"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89366165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信